CIK 0001377121 · Large accelerated filer
Protagonist Therapeutics, Inc
Sign in to watch- Ticker
- PTGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980505495
- Phone
- (510) 474-0170
- Business address
- 7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
- Former names
- Protagonist Therapeutics Inc, Protagonist Inc
- 4 Open-market sale Chief Financial Officer sold 8,588 shares at $82.48 ($708,338)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Option exercise Director acquired 14,299 shares (option exercise)
- 8-K Event Regulation FD disclosure
- 4 Grant or award Director acquired 2,695 shares (grant or award)
- 4 Grant or award Director acquired 2,695 shares (grant or award)
- 4 Grant or award Director acquired 2,695 shares (grant or award)
- 4 Grant or award Director acquired 2,695 shares (grant or award)
- 4 Grant or award Director acquired 2,695 shares (grant or award)
- 4 Grant or award President and CEO acquired 95,400 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 25,600 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 25,600 shares (grant or award)
- 4 Gift President and CEO gave 440 shares (gift)
- 4 Open-market sale Chief Medical Officer sold 2,712 shares at $84.77 ($229,896)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
Page 5 of 36 · 707 filings